Biological Information

Background Information:

Leukotriene (LT) receptors most sensitive to the endogenous ligand BLT4 are named BLT receptors, whereas those preferentially activated by the CysLTs are named LTC4, D4 and E4. LT receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. LTB4 receptors are found in leukocytes, spleen and thymus and also reported to be present in peritoneal macrophages and eosinophils.

No. of Assays on Panel:

2

Assays on Panel:

Family

GPCR

Name

Item

1245

Protein

BLT1 (LTB4)

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1837

Protein

BLT1 (LTB4)

Organism

Human

Assay Sub Type

Cell Based

Family:

GPCR

Sub Family:

Leukotriene

Class:

Class A

Protein Name:

BLT1 (LTB4)

Uniprot Number:

Q15722

Protein Aliases:

LTB4-R1|Chemoattractant receptor-like 1|G-protein coupled receptor 16|P2Y purinoceptor 7|P2Y7

Gene Name:

LTB4R

Gene ID:

1241

Gene Aliases:

BLT|BLT1|BLTR|CMKRL1|GPR16|P2RY7

Organism:

Human

Cell Type:

CHO-K1

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Agonist & Antagonist

Detection Method:

Fluorimetry

Measured Response:

Fluorescence

Testing Information

Incubation:

RT

Control Activator:

LTB4 (10 nM)

Test Concentration / Dose:

Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.

Test Sample Requirements:

Minimum for 1) Screen: 70 µL of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM finµL testing. 2) Dose Response: 90 µL of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.

Minimum Order Quantity:

16

Turnaround Time

Standard:

15 Business Days

Clinical Relevance

Therapeutic Area:

Pulmonology

Adverse / Beneficial Action:

LTB4 receptor agonism promotes neutrophil chemotaxis and secretion contributing to inflammation, but may also affect immunomodulation, etc. BLT receptor antagonism may be useful in the treatment of pulmonary inflammation (COPD, asthma) and ulcerative colitis.

Additional Information

Brand:

LeadHunter

Testing Location:

France - Celle L'Evescault

RELATED SOLUTIONS

Item: 1245
Item: 1837